[CASE] Astra Zeneca: Meeting between doctor and patient

Discover how we helped Astra Zeneca get even closer to the target group. Since 2009, our Moment of Truth method has provided unique insight into how Astra Zenecas products are actually presented and perceived in medical consultation.

Go to Danish version.

Astra Zeneca is a leader in asthma treatment in the Nordic markets. Symbicort and the associated Turbuhaler inhaler are brands recognised by both doctors and patients. Astra Zeneca nonetheless needs to get even closer to the target groups.

Since 2009, Ipsos’ Moment of Truth method has provided unique insight into how Symbicort/Turbuhaler are actually presented and perceived in medical consultation. The results comprised a core component of a larger research project in Denmark, Sweden, Norway and Finland. Astra Zeneca uses the results to develop market strategy and improve patient compliance.

Meeting between doctor and patient | Astra Zeneca | Ipsos

Want to know more?

Contact Asger Mortensen, Head of Ipsos UU

Contact Asger Mortensen, Head of Ipsos UU
Phone: +45 6167 3737
Email: [email protected]

 

Download

Related news

  • Live Event: Customer Experience | Ipsos Denmark
    Customer Experience Event

    LIVE EVENT: Customer Experience

    Join our live event on Customer Experience (CX) on the 9th of March to learn from 6 key speakers as they share their take on this topic. You’ll leave the event with insights, inspiration and tools to elevate the experience your customers have when interacting with your business.
  • [Webinar] Ipsos CX Global Voices 2022
    Customer Experience Webinar

    [Webinar] Ipsos CX Global Voices 2022

    Hear from our global customer experience experts, as they unpack the results of the Ipsos 2022 CX Global Voices Survey conducted among 1,000+ CX professionals, from over 65 markets.